Application 202887

Type
ANDA
Sponsor
RUBICON

Application Products#

Product, Drug, Ingredient table
ProductDrugIngredientFormStrengthReference drugReference standard
001LAMOTRIGINELAMOTRIGINETABLET, EXTENDED RELEASE;ORAL25MGNoNo
002LAMOTRIGINELAMOTRIGINETABLET, EXTENDED RELEASE;ORAL50MGNoNo
003LAMOTRIGINELAMOTRIGINETABLET, EXTENDED RELEASE;ORAL100MGNoNo
004LAMOTRIGINELAMOTRIGINETABLET, EXTENDED RELEASE;ORAL200MGNoNo

NDC Listings For This Application#

NDC, Name, Nonproprietary name table
NDCNameNonproprietary nameLabelerMarketing categoryStatus
52817-240Lamotrigine Extended Releaselamotrigine extended releaseTruPharma, LLCANDACurrent
52817-240Lamotrigine Extended Releaselamotrigine extended releaseTruPharma, LLCANDACurrent
52817-240Lamotrigine Extended Releaselamotrigine extended releaseTruPharma, LLCANDACurrent
52817-241Lamotrigine Extended Releaselamotrigine extended releaseTruPharma, LLCANDACurrent
52817-241Lamotrigine Extended Releaselamotrigine extended releaseTruPharma, LLCANDACurrent
52817-241Lamotrigine Extended Releaselamotrigine extended releaseTruPharma, LLCANDACurrent
52817-242Lamotrigine Extended Releaselamotrigine extended releaseTruPharma, LLCANDACurrent
52817-242Lamotrigine Extended Releaselamotrigine extended releaseTruPharma, LLCANDACurrent
52817-242Lamotrigine Extended Releaselamotrigine extended releaseTruPharma, LLCANDACurrent
52817-243Lamotrigine Extended Releaselamotrigine extended releaseTruPharma, LLCANDACurrent
52817-243Lamotrigine Extended Releaselamotrigine extended releaseTruPharma, LLCANDACurrent
52817-243Lamotrigine Extended Releaselamotrigine extended releaseTruPharma, LLCANDACurrent